AGNPF — Algernon Health Inc.

OTC · Health Care · Pharmaceuticals · CIK 1642178 · British Columbia, Canada
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Health Inc. and changed its name to Grey Matters Health Inc. in April 2026. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Feb 2026 0 -499,628 -499,524 4,948,564 195,349 2,493,598
Nov 2025 0 -597,203 -597,007 4,928,680 210,030 2,443,289
Aug 2025 0 -380,733 -380,500 4,877,474 176,501 2,182,240
May 2025 0 -583,211 -583,225 4,881,105 88,176 3,139,546

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,269,912
Investing CF
$161,221
Financing CF
$974,100
CapEx
$-41,035
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.60
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-30,763,888
Inventory
Receivables
$15,845
ST Investments
EBIT TTM
$-1,933,674
Pretax Income TTM
$-1,932,999
Interest Exp TTM
$14
Analysts

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Aug 2025 0 -1,717,794 -1,717,055 4,877,474 2,182,240 -1,157,041
Aug 2024 0 -2,412,042 -502,982 3,944,040 1,775,447 -2,709,577
Aug 2023 0 -5,241,991 -6,781,200 4,193,699 2,719,760 -2,553,008
Aug 2022 0 -6,019,955 -6,054,356 8,140,757 2,516,099 -2,912,741

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $949.47B $1064.74
JNJ JOHNSON & JOHNSON $554.09B $230.18
ABBV AbbVie Inc. $376.54B $213.12
MRK Merck & Co., Inc. $295.69B $119.72
AZN ASTRAZENECA PLC $290.30B $187.19

News headlines (Yahoo Finance, 1h cache)

Grey Matters Improves Warrant Terms of Private Placement
2026-05-25 11:00 · Yahoo
Grey Matters Announces Private Placement
2026-04-22 11:00 · Yahoo
Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation
2026-04-15 20:01 · Yahoo
Algernon Health to rebrand as Grey Matters Health, sharpen focus on Alzheimer’s diagnostics
2026-04-01 12:45 · Yahoo
Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation
2026-03-31 23:09 · Yahoo
Algernon Health CEO outlines US brain imaging network plans - ICYMI
2026-03-28 13:00 · Yahoo
Algernon Health highlights NovaScan brand for dedicated brain PET scanning centers
2026-03-25 13:59 · Yahoo
Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers
2026-03-25 11:00 · Yahoo
Dow finishes higher as markets cheer potential Strait of Hormuz reopening
2026-03-23 20:20 · Yahoo
Algernon Health to open brain-focused PET scanning clinic in Florida
2026-03-23 12:37 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.